The study team produced single-cell laser injuries and tracked intracellular calcium in endothelial monolayers and intact mesenteric vessels. A coherent Ca2+ wavefront radiated from the wound, spreading rapidly at first and then progressively slowing. The investigators reported a consistent termination distance of 197 ± 7 μm from the injury site and engagement of 50 ± 8 cells on average. These quantitative boundaries recurred across preparations, establishing a reproducible spatial extent for propagating Ca2+ signals after focal endothelial damage.
Neighboring cells in the first ring around the wound produced a qualitatively different response than cells farther away. The study team observed that the first-ring response was prevented by carbenoxolone. By contrast, continued propagation beyond this immediate ring required extracellular ATP, activation of purinergic receptors, and IP3-dependent Ca2+ release from intracellular stores. The authors therefore separated two mechanistic phases: an initial, carbenoxolone-sensitive coupling to immediate neighbors, followed by an ATP-driven, purinergic/IP3-dependent propagation phase. Wavefront kinematics matched expectations for ATP diffusion mediating the longer-range signal.
To test relevance in vivo, the investigators performed intravital Ca2+ imaging. Injury induced a vasoconstrictive response and produced bidirectional Ca2+ waves that propagated before terminating. The in vivo termination distance measured 205 ± 28 μm, a value similar to the in vitro boundary. These observations link the spatial dynamics of endothelial Ca2+ signaling to a physiological vascular response—vasoconstriction—seen in the live preparation.
The authors measured phospholipid scrambling by assaying phosphatidylserine (PS) externalization. Remarkably, despite widespread endothelial Ca2+ elevations across the propagation field, PS externalization remained confined to the single wounded cell in both monolayer cultures and intact vessels imaged in vitro. The cohort therefore showed a spatial uncoupling: the intercellular Ca2+ wave propagated broadly, yet the procoagulant membrane change was tightly localized. The investigators reported that the endothelial surface maintained localization of the PS signal even when neighboring cells exhibited clear Ca2+ transients.
The team compared injury-evoked signaling with a pharmacologic Ca2+ overload. Application of ionomycin, which produces sustained high intracellular Ca2+, led to PS exposure across nearly all endothelial cells. This contrast demonstrated that generalized, unregulated Ca2+ overload can activate phospholipid scrambling widely, whereas the physiological injury wave—despite elevating Ca2+ in many cells—did not produce the same outcome. Authors concluded that Ca2+-dependent scramblase activation requires more than a transient or moderate rise in Ca2+ alone under these experimental conditions.
Data indicated that endothelial Ca2+ signaling can disseminate injury information across a broad field while maintaining a highly localized procoagulant membrane response, implying additional spatial regulation of scramblase activation beyond Ca2+ elevation. The study team observed that propagation depended on an initial carbenoxolone-sensitive neighbor coupling and then on ATP-mediated purinergic signaling with IP3-driven release, and that wave kinematics fit an ATP diffusion model.
The source did not report specific molecular identities of the scramblase(s) responsible for PS exposure in this system, nor did it provide comprehensive limitations of the experimental models beyond the presented observations. The authors did not list translational steps, clinical dosing, or longer-term functional consequences of localized versus widespread endothelial scrambling. Those gaps define concrete next questions: which scramblase proteins are spatially gated, what molecular brakes prevent scramblase activation in cells that experience Ca2+ transients, and how these mechanisms influence thrombosis risk in vivo.
Limitations explicitly absent from the preprint were noted: the manuscript did not report detailed constraints on model generalizability across vascular beds, nor did it include identification of the scramblase molecular machinery or time-course data linking transient Ca2+ elevations to downstream coagulation metrics. These omissions limit immediate clinical extrapolation but define testable experimental priorities for follow-up studies.